1. Home
  2. XOMA vs RWAY Comparison

XOMA vs RWAY Comparison

Compare XOMA & RWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOMA
  • RWAY
  • Stock Information
  • Founded
  • XOMA 1981
  • RWAY 2015
  • Country
  • XOMA United States
  • RWAY United States
  • Employees
  • XOMA N/A
  • RWAY N/A
  • Industry
  • XOMA Biotechnology: Pharmaceutical Preparations
  • RWAY
  • Sector
  • XOMA Health Care
  • RWAY
  • Exchange
  • XOMA Nasdaq
  • RWAY Nasdaq
  • Market Cap
  • XOMA 355.6M
  • RWAY 390.5M
  • IPO Year
  • XOMA N/A
  • RWAY 2021
  • Fundamental
  • Price
  • XOMA $30.21
  • RWAY $10.41
  • Analyst Decision
  • XOMA Strong Buy
  • RWAY Buy
  • Analyst Count
  • XOMA 2
  • RWAY 9
  • Target Price
  • XOMA $78.50
  • RWAY $11.68
  • AVG Volume (30 Days)
  • XOMA 30.4K
  • RWAY 332.4K
  • Earning Date
  • XOMA 11-07-2024
  • RWAY 11-12-2024
  • Dividend Yield
  • XOMA N/A
  • RWAY 17.77%
  • EPS Growth
  • XOMA N/A
  • RWAY N/A
  • EPS
  • XOMA N/A
  • RWAY 1.02
  • Revenue
  • XOMA $21,606,000.00
  • RWAY $150,078,000.00
  • Revenue This Year
  • XOMA $488.61
  • RWAY N/A
  • Revenue Next Year
  • XOMA $27.42
  • RWAY N/A
  • P/E Ratio
  • XOMA N/A
  • RWAY $10.17
  • Revenue Growth
  • XOMA 389.82
  • RWAY N/A
  • 52 Week Low
  • XOMA $14.33
  • RWAY $9.87
  • 52 Week High
  • XOMA $33.78
  • RWAY $13.74
  • Technical
  • Relative Strength Index (RSI)
  • XOMA 52.03
  • RWAY 51.16
  • Support Level
  • XOMA $29.09
  • RWAY $10.08
  • Resistance Level
  • XOMA $32.50
  • RWAY $10.17
  • Average True Range (ATR)
  • XOMA 1.87
  • RWAY 0.20
  • MACD
  • XOMA -0.17
  • RWAY 0.02
  • Stochastic Oscillator
  • XOMA 49.29
  • RWAY 72.66

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.

About RWAY Runway Growth Finance Corp.

Runway Growth Finance Corp is a specialty finance company focused on providing senior secured loans to high-growth-potential companies in technology, life sciences, healthcare information and services, business services, select consumer services and products, and other high-growth industries. The company has Investments in the United States, Germany, and Canada, with the majority of its portfolio invested in the United States.

Share on Social Networks: